JPS5770857A - Guanidine derivative, manufacture and histamine h-2 antagonist containing same - Google Patents

Guanidine derivative, manufacture and histamine h-2 antagonist containing same

Info

Publication number
JPS5770857A
JPS5770857A JP56118592A JP11859281A JPS5770857A JP S5770857 A JPS5770857 A JP S5770857A JP 56118592 A JP56118592 A JP 56118592A JP 11859281 A JP11859281 A JP 11859281A JP S5770857 A JPS5770857 A JP S5770857A
Authority
JP
Japan
Prior art keywords
histamine
manufacture
containing same
guanidine derivative
antagonist containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP56118592A
Other languages
English (en)
Inventor
Oregon Ierin Tobiasu
Jiyon Giruman Debuitsuto
Fureeto Jiyonsu Deriku
Oorudohamu Keito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Zeneca Inc
Original Assignee
Imperial Chemical Industries Ltd
ICI Americas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd, ICI Americas Inc filed Critical Imperial Chemical Industries Ltd
Publication of JPS5770857A publication Critical patent/JPS5770857A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP56118592A 1980-07-30 1981-07-30 Guanidine derivative, manufacture and histamine h-2 antagonist containing same Pending JPS5770857A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8024963 1980-07-30

Publications (1)

Publication Number Publication Date
JPS5770857A true JPS5770857A (en) 1982-05-01

Family

ID=10515153

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56118592A Pending JPS5770857A (en) 1980-07-30 1981-07-30 Guanidine derivative, manufacture and histamine h-2 antagonist containing same

Country Status (5)

Country Link
US (1) US4464374A (ja)
EP (1) EP0045155B1 (ja)
JP (1) JPS5770857A (ja)
CA (1) CA1220478A (ja)
DE (1) DE3168031D1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI76795C (fi) * 1979-09-04 1988-12-12 Bristol Myers Co Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 3,4-disubstituerade 1,2,5-tiadiazol-1-oxider och -1,1-dioxider samt nya mellanprodukter.
DE3270716D1 (en) * 1981-02-27 1986-05-28 Ici Plc Guanidino-substituted heterocyclic derivatives having histamine h-2 antagonist activity
US4460584A (en) * 1981-03-13 1984-07-17 Imperial Chemical Industries Plc Nitrogen heterocycles
IN158869B (ja) * 1981-03-18 1987-02-07 Ici Plc
FR2526431A1 (fr) * 1982-05-10 1983-11-10 Sanofi Sa Thioalkylnicotinamide 1-oxyde, ses sels, procede pour leur preparation et compositions pharmaceutiques en contenant
US4501747A (en) * 1982-05-10 1985-02-26 Sanofi Certain amide derivatives of 2-guanidino-thiazoles and compositions containing same
JPS59104370A (ja) * 1982-12-03 1984-06-16 Kotobuki Seiyaku Kk チアゾ−ル誘導体及びその製造方法
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4692531A (en) * 1984-06-22 1987-09-08 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
DE3532880A1 (de) * 1985-09-14 1987-03-26 Basf Ag 1,4-disubstituierte pyrazolderivate
KR890014504A (ko) * 1988-03-11 1989-10-24 우대규 4-(2'-시아노 에틸티오)메틸-2-구아니디노티아졸의 제조방법
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53118592A (en) * 1977-03-23 1978-10-17 Dai Ichi Seiyaku Co Ltd Preparation of high purity adenosine triphosphoric acid aqueous solution
JPS5553247A (en) * 1978-10-17 1980-04-18 Shionogi & Co Ltd Novel benzylamine derivative
JPS5581838A (en) * 1978-11-16 1980-06-20 Glaxo Group Ltd Novel alpha*omegaadisubstituted polymethylene compound

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
NZ186965A (en) * 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
GB2001624B (en) * 1977-04-20 1982-03-03 Ici Ltd Guanidine derivatives processes for their manufacture and pharmaceutical compositions containing them
JPS54132566A (en) * 1978-01-18 1979-10-15 Ici Ltd Guanidine derivative*its manufacture and secretion controlling pharmaceutical composition containing it
EP0010893B1 (en) * 1978-10-16 1984-02-08 Imperial Chemical Industries Plc Antisecretory branched-chain heterocyclic guanidine derivatives, processes for their manufacture, intermediates, and pharmaceutical compositions containing said derivatives
US4309435A (en) * 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
DE3069889D1 (en) * 1979-01-18 1985-02-14 Ici Plc Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
JPS6056143B2 (ja) * 1979-08-02 1985-12-09 山之内製薬株式会社 アミジン誘導体ならびにその製造法
GR71929B (ja) * 1979-11-13 1983-08-19 Ici Ltd

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53118592A (en) * 1977-03-23 1978-10-17 Dai Ichi Seiyaku Co Ltd Preparation of high purity adenosine triphosphoric acid aqueous solution
JPS5553247A (en) * 1978-10-17 1980-04-18 Shionogi & Co Ltd Novel benzylamine derivative
JPS5581838A (en) * 1978-11-16 1980-06-20 Glaxo Group Ltd Novel alpha*omegaadisubstituted polymethylene compound

Also Published As

Publication number Publication date
CA1220478A (en) 1987-04-14
DE3168031D1 (en) 1985-02-14
EP0045155A1 (en) 1982-02-03
US4464374A (en) 1984-08-07
EP0045155B1 (en) 1985-01-02

Similar Documents

Publication Publication Date Title
DE3171325D1 (en) Tridecyloxy- or tetradecyloxy-propane derivatives, and their use
IL80463A (en) 2-desoxy-2,2-difluoro-furanose derivatives
JPS56164115A (en) Antihypertensive
EP0112707A3 (en) Aminopyrimidinone derivatives as histamine h1-antagonists
JPS5770857A (en) Guanidine derivative, manufacture and histamine h-2 antagonist containing same
ZA801002B (en) Histamine antagonists
ES533537A0 (es) Triazol (2,3-c)pirimidin-aminas(-amidas)
JPS5753484A (en) Imidazolidinone derivative, manufacture and herbicide containing same
JPS5795971A (en) Compound, manufacture and use
DE3268615D1 (en) Guanidine derivatives
IL73471A0 (en) N,n-di-n-propyl-4-hydroxy-3-methanesulfonamidophenethylamine
JPS56161364A (en) Novel guanidine derivative, its manufacture and its use
JPS57159784A (en) Pyridine compound, manufacture and use
JPS5795973A (en) Compound, manufacture and use
GB2080107B (en) Antidiarrhoeal guanidine derivatives
DE3363527D1 (en) Aminopyrimidinone derivatives useful as histamine h1-antagonists
JPS5795974A (en) Compound, manufacture and use
ZA843772B (en) Substituted tetrahydrothiopyran-3,5-dione-4-carboxamides
DE3174954D1 (en) Side-dumping, material-hauling conveyance
JPS57126468A (en) Antihypertensive
JPS5753471A (en) Triazolylpropenol derivative, manufacture and use
DE3468859D1 (en) Substituted 5-cycloalkyl-2,2-dimethyl-pentan-3-one
JPS57123167A (en) 2-alkyl-5-alkylsulfonyl-4,6-dihalogen pyrimidine and manufacture
GB2068378B (en) Guanidine derivatives
DE3169834D1 (en) N,n-diacylaminoperfluoroalkanesulfonanilides and derivatives thereof